Literature DB >> 9566700

Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice.

H Hayashi1, M Kanisawa, K Yamanaka, T Ito, N Udaka, H Ohji, K Okudela, S Okada, H Kitamura.   

Abstract

The pulmonary tumorigenicity of dimethylarsinic acid (DMAA), a main metabolite of inorganic arsenics, was examined in A/J mice fed with drinking water containing DMAA for 25 and 50 weeks. Mice fed with 400 ppm DMAA for 50 weeks produced more pulmonary tumors than untreated mice (mean number per animal 1.36 versus 0.50; P < 0.05). Histological examination revealed that the number of mice which bore adenocarcinomas or papillary adenomas correlated with the concentration of DMAA given (untreated versus 400 ppm; P = 0.002), suggesting that DMAA could promote tumorigenic processes. These results are consistent with the epidemiological studies on the pulmonary carcinogenesis of arsenics and suggest that DMAA alone can act as a carcinogen in mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566700     DOI: 10.1016/s0304-3835(97)00484-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

Review 2.  Cancer in experimental animals exposed to arsenic and arsenic compounds.

Authors:  Erik J Tokar; Lamia Benbrahim-Tallaa; Jerrold M Ward; Ruth Lunn; Reeder L Sams; Michael P Waalkes
Journal:  Crit Rev Toxicol       Date:  2010-11       Impact factor: 5.635

3.  Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice.

Authors:  Erik J Tokar; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Toxicol Lett       Date:  2011-12-31       Impact factor: 4.372

Review 4.  Comparative pathobiology of environmentally induced lung cancers in humans and rodents.

Authors:  Arun Pandiri
Journal:  Toxicol Pathol       Date:  2014-10-27       Impact factor: 1.902

Review 5.  Oxidative mechanism of arsenic toxicity and carcinogenesis.

Authors:  Honglian Shi; Xianglin Shi; Ke Jian Liu
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

6.  Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration.

Authors:  Michael F Hughes; Vicenta Devesa; Blakely M Adair; Sean D Conklin; John T Creed; Miroslav Styblo; Elaina M Kenyon; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2007-10-22       Impact factor: 4.219

Review 7.  Tumor-augmenting effects of gestational arsenic exposure on F1 and F2 in mice.

Authors:  Keiko Nohara; Takehiro Suzuki; Kazuyuki Okamura; Junya Matsushita; Shota Takumi
Journal:  Genes Environ       Date:  2017-03-01

8.  Joint effects of genomic markers and urinary methylation capacity associated with inorganic arsenic metabolism on the occurrence of cancers among residents in arseniasis-endemic areas: A cohort subset with average fifteen-year follow-up.

Authors:  Pei-Ju Liao; Kuang-Hung Hsu; Hung-Yi Chiou; Chien-Jen Chen; Chih-Hung Lee
Journal:  Biomed J       Date:  2020-10-13       Impact factor: 7.892

9.  Pharmacokinetic and Genomic Effects of Arsenite in Drinking Water on Mouse Lung in a 30-Day Exposure.

Authors:  Jaya Chilakapati; Kathleen Wallace; Araceli Hernandez-Zavala; Tanya Moore; Hongzu Ren; Kirk T Kitchin
Journal:  Dose Response       Date:  2015-06-30       Impact factor: 2.658

10.  Inhalation toxicity of particulate matters doped with arsenic induced genotoxicity and altered akt signaling pathway in lungs of mice.

Authors:  Jin Hong Park; Jung-Taek Kwon; Minai-Teherani Arassh; Soon-Kyung Hwang; Seung-Hee Chang; Hwang Tae Lim; Hyun-Seon Cho; Myung-Haing Cho
Journal:  Toxicol Res       Date:  2010-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.